HTFL
insider transactionsHeartflow, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-4.3M
0 buy · 4.3M sell
Net value · 365d
-$123.6M
$0 in · $123.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
17
0 buy · 4.3M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
10.0K sh
Own +16%
-
Exercise·M
Chief Medical Officer · 10b5-1
$22.2K
10.0K sh · $2.22
Own +13%
-
Sell·S
Chief Executive Officer · 10b5-1
$643.0K
22.6K sh · $28.50
Own -4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
9.2K sh
Own +10%
-
Sell·S
Chief Medical Officer · 10b5-1
$261.3K
9.2K sh · $28.34
Own -10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$175.2K
9.2K sh · $19.00
Own +12%
-
Sell·S
Chief Executive Officer · 10b5-1
$657.0K
22.6K sh · $29.12
Own -4%
-
Other·F
Chief Accounting Officer
$2.5K
82 sh · $29.98
Own -0%
-
Other·F
Chief Medical Officer
$19.1K
637 sh · $29.98
Own -1%
-
Other·F
Vikram Verghese KEY
Chief Financial Officer
$14.2K
473 sh · $29.98
Own -0%
-
Other·F
Chief Executive Officer
$57.1K
1.9K sh · $29.98
Own -0%
-
Other·F
Chief Accounting Officer
$14.7K
485 sh · $30.29
Own -2%
-
Other·F
Chief Medical Officer
$49.5K
1.6K sh · $30.29
Own -2%
-
Other·F
Vikram Verghese KEY
Chief Financial Officer
$46.5K
1.5K sh · $30.29
Own -1%
-
Other·F
Chief Executive Officer
$160.5K
5.3K sh · $30.29
Own -1%
-
Sell·S
-
Sell·S
-
Sell·S
-
Sell·S
-
Sell·S
Chief Executive Officer · 10b5-1
$602.9K
22.6K sh · $26.72
Own -4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
40.8K sh
Own +100%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
19.1K sh
Own +19%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
291 sh
Own +10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
6.8K sh
Own New
-
Sell·S
Chief Medical Officer · 10b5-1
$1.6M
64.5K sh · $24.64
Own -44%
-
Exercise·M
Chief Medical Officer · 10b5-1
$15.2K
6.8K sh · $2.22
Own +5%
-
Exercise·M
Chief Medical Officer · 10b5-1
$90.5K
40.8K sh · $2.22
Own +42%
-
Exercise·M
Chief Medical Officer · 10b5-1
$42.4K
19.1K sh · $2.22
Own +24%
-
Exercise·M
Chief Medical Officer · 10b5-1
$2.4K
291 sh · $8.33
Own +0%
-
Other·J
Director
$0
206.3K sh
-
Other·J
HealthCor Partners Management LP
Director
—
4.6M sh
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
47.6K sh
Own +51%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
19.4K sh
Own +11%
-
Sell·S
Chief Medical Officer · 10b5-1
$1.7M
64.5K sh · $25.69
Own -45%
-
Exercise·M
Chief Medical Officer · 10b5-1
$105.7K
47.6K sh · $2.22
Own +50%
-
Exercise·M
Chief Medical Officer · 10b5-1
$43.1K
19.4K sh · $2.22
Own +26%
-
Sell·S
Chief Executive Officer · 10b5-1
$243.1K
9.7K sh · $25.00
Own -2%
-
Exercise·M
Director
$0
8.7K sh
Own +128%
-
Exercise·M
Director
$19.2K
8.7K sh · $2.22
Own +5%
-
Sell·S
Chief Executive Officer · 10b5-1
$290.9K
12.8K sh · $22.66
Own -2%
-
Grant·A
Chief Executive Officer · 10b5-1
$42.5K
2.6K sh · $16.15
Own +0%
-
Sell·S
Director · 10b5-1
$228.1K
9.1K sh · $25.00
Own -25%
-
Exercise·M
Director
$0
2.5K sh
Own New
-
Exercise·M
Director
$20.8K
2.5K sh · $8.33
Own +1%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
7.9K sh
Own +4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
19.4K sh
Own +10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
39.7K sh
Own New
-
Sell·S
Chief Medical Officer · 10b5-1
$1.6M
65.2K sh · $24.49
Own -46%
-
Exercise·M
Chief Medical Officer · 10b5-1
$17.6K
7.9K sh · $2.22
Own +6%
-
Exercise·M
Chief Medical Officer · 10b5-1
$330.8K
39.7K sh · $8.33
Own +42%
-
Exercise·M
Chief Medical Officer · 10b5-1
$43.1K
19.4K sh · $2.22
Own +26%
-
Sell·S
Chief Executive Officer · 10b5-1
$619.6K
22.6K sh · $27.46
Own -4%
-
Grant·A
Chief Accounting Officer, VP
$0
37.8K sh
Own New
-
Grant·A
Chief Accounting Officer, VP
$0
21.6K sh
Own +216%
-
Other·F
Chief Accounting Officer, VP
$2.6K
94 sh · $27.74
Own -1%
-
Grant·A
Chief Medical Officer
$0
94.5K sh
Own New
-
Grant·A
Chief Medical Officer
$0
54.1K sh
Own +269%
-
Other·F
Chief Medical Officer
$14.3K
515 sh · $27.74
Own -2%
-
Grant·A
Vikram Verghese KEY
Chief Financial Officer
$0
119.7K sh
Own New
-
Grant·A
Vikram Verghese KEY
Chief Financial Officer
$0
68.5K sh
Own +47%
-
Other·F
Vikram Verghese KEY
Chief Financial Officer
$15.0K
542 sh · $27.74
Own -0%
-
Grant·A
Chief Executive Officer · 10b5-1
$0
321.3K sh
Own New
-
Grant·A
Chief Executive Officer · 10b5-1
$0
183.8K sh
Own +43%
-
Other·F
Chief Executive Officer · 10b5-1
$42.7K
1.5K sh · $27.74
Own -0%
-
Sell·S
Director · 10b5-1
$218.6K
8.0K sh · $27.32
Own -18%
-
Sell·S
-
Grant·A
Director
$0
7.8K sh
Own New
-
Grant·A
Director
$0
2.6K sh
Own +5%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | William C Weldon | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Jeffrey C Lightcap | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Wayne Joseph Riley | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Casey M Tansey | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Julie A Cullivan | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Timothy C Barabe | Grant A | 16.1K | $515.2K |
| Jun 15, 2026 | Campbell Rogers 10b5-1 | Exercise M | 10.0K | $0 |
| Jun 15, 2026 | Campbell Rogers 10b5-1 | Exercise M | 10.0K | $22.2K |
| Jun 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $643.0K |
| May 18, 2026 | Campbell Rogers 10b5-1 | Exercise M | 9.2K | $0 |
| May 18, 2026 | Campbell Rogers 10b5-1 | Sell S | 9.2K | $261.3K |
| May 18, 2026 | Campbell Rogers 10b5-1 | Exercise M | 9.2K | $175.2K |
| May 11, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $657.0K |
| May 7, 2026 | Marie L. Jones | Other F | 82 | $2.5K |
| May 7, 2026 | Campbell Rogers | Other F | 637 | $19.1K |
| May 7, 2026 | Vikram Verghese KEY | Other F | 473 | $14.2K |
| May 7, 2026 | John C.M. Farquhar KEY | Other F | 1.9K | $57.1K |
| May 6, 2026 | Marie L. Jones | Other F | 485 | $14.7K |
| May 6, 2026 | Campbell Rogers | Other F | 1.6K | $49.5K |
| May 6, 2026 | Vikram Verghese KEY | Other F | 1.5K | $46.5K |
| May 6, 2026 | John C.M. Farquhar KEY | Other F | 5.3K | $160.5K |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 56.2K | $1.7M |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 892.5K | $26.0M |
| Apr 29, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 797.1K | $23.4M |
| Apr 28, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 254.1K | $7.8M |
| Apr 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $602.9K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 40.8K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.1K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 291 | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 6.8K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Sell S | 64.5K | $1.6M |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 6.8K | $15.2K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 40.8K | $90.5K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.1K | $42.4K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 291 | $2.4K |
| Mar 24, 2026 | Jeffrey C Lightcap | Other J | 206.3K | $0 |
| Mar 24, 2026 | HealthCor Partners Management LP | Other J | 4.6M | — |
| Mar 19, 2026 | Campbell Rogers 10b5-1 | Exercise M | 47.6K | $0 |
| Mar 19, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.4K | $0 |
| Mar 19, 2026 | Campbell Rogers 10b5-1 | Sell S | 64.5K | $1.7M |
| Mar 19, 2026 | Campbell Rogers 10b5-1 | Exercise M | 47.6K | $105.7K |
| Mar 19, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.4K | $43.1K |
| Mar 18, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 9.7K | $243.1K |
| Mar 11, 2026 | Timothy C Barabe | Exercise M | 8.7K | $0 |
| Mar 11, 2026 | Timothy C Barabe | Exercise M | 8.7K | $19.2K |
| Mar 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 12.8K | $290.9K |
| Mar 6, 2026 | John C.M. Farquhar KEY 10b5-1 | Grant A | 2.6K | $42.5K |
| Mar 5, 2026 | Julie A Cullivan 10b5-1 | Sell S | 9.1K | $228.1K |
| Feb 17, 2026 | Timothy C Barabe | Exercise M | 2.5K | $0 |
| Feb 17, 2026 | Timothy C Barabe | Exercise M | 2.5K | $20.8K |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 7.9K | $0 |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.4K | $0 |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 39.7K | $0 |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Sell S | 65.2K | $1.6M |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 7.9K | $17.6K |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 39.7K | $330.8K |
| Feb 12, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.4K | $43.1K |
| Feb 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $619.6K |
| Feb 6, 2026 | Marie L. Jones | Grant A | 37.8K | $0 |
| Feb 6, 2026 | Marie L. Jones | Grant A | 21.6K | $0 |
| Feb 6, 2026 | Marie L. Jones | Other F | 94 | $2.6K |
| Feb 6, 2026 | Campbell Rogers | Grant A | 94.5K | $0 |
| Feb 6, 2026 | Campbell Rogers | Grant A | 54.1K | $0 |
| Feb 6, 2026 | Campbell Rogers | Other F | 515 | $14.3K |
| Feb 6, 2026 | Vikram Verghese KEY | Grant A | 119.7K | $0 |
| Feb 6, 2026 | Vikram Verghese KEY | Grant A | 68.5K | $0 |
| Feb 6, 2026 | Vikram Verghese KEY | Other F | 542 | $15.0K |
| Feb 6, 2026 | John C.M. Farquhar KEY 10b5-1 | Grant A | 321.3K | $0 |
| Feb 6, 2026 | John C.M. Farquhar KEY 10b5-1 | Grant A | 183.8K | $0 |
| Feb 6, 2026 | John C.M. Farquhar KEY 10b5-1 | Other F | 1.5K | $42.7K |
| Feb 5, 2026 | Julie A Cullivan 10b5-1 | Sell S | 8.0K | $218.6K |
| Feb 4, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 2.0M | $56.1M |
| Jan 2, 2026 | Timothy C Barabe | Grant A | 7.8K | $0 |
| Jan 2, 2026 | Timothy C Barabe | Grant A | 2.6K | $0 |
About HTFL insider trading
This page tracks insider transactions for Heartflow, Inc. (HTFL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.